Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies
| Errataetall: |
CommentIn: J Infect. 2021 Sep;83(3):381-412. - PMID 34147528 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
|---|---|
| Enthalten in: |
The Journal of infection - 83(2021), 2 vom: 01. Aug., Seite 237-279 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Breathnach, Aodhán Seán [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 30.07.2021 Date Revised 02.03.2022 published: Print-Electronic CommentIn: J Infect. 2021 Sep;83(3):381-412. - PMID 34147528 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2021.05.024 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326008977 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326008977 | ||
| 003 | DE-627 | ||
| 005 | 20231225193648.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2021.05.024 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1086.xml |
| 035 | |a (DE-627)NLM326008977 | ||
| 035 | |a (NLM)34052242 | ||
| 035 | |a (PII)S0163-4453(21)00266-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Breathnach, Aodhán Seán |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.07.2021 | ||
| 500 | |a Date Revised 02.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: J Infect. 2021 Sep;83(3):381-412. - PMID 34147528 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Duncan, Christopher James Arthur |e verfasserin |4 aut | |
| 700 | 1 | |a Bouzidi, Kate El |e verfasserin |4 aut | |
| 700 | 1 | |a Hanrath, Aidan Taeke |e verfasserin |4 aut | |
| 700 | 1 | |a Payne, Brendan Alexander Ingelby |e verfasserin |4 aut | |
| 700 | 1 | |a Randell, Paul Anthony |e verfasserin |4 aut | |
| 700 | 1 | |a Habibi, Maximillian Shahin |e verfasserin |4 aut | |
| 700 | 1 | |a Riley, Peter Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Planche, Timothy David |e verfasserin |4 aut | |
| 700 | 1 | |a Busby, John Samuel |e verfasserin |4 aut | |
| 700 | 1 | |a Sudhanva, Malur |e verfasserin |4 aut | |
| 700 | 1 | |a Pallett, Scott John Charles |e verfasserin |4 aut | |
| 700 | 1 | |a Kelleher, William Peter |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 83(2021), 2 vom: 01. Aug., Seite 237-279 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:83 |g year:2021 |g number:2 |g day:01 |g month:08 |g pages:237-279 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2021.05.024 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2021 |e 2 |b 01 |c 08 |h 237-279 | ||